Insider · CIK 0002110997
David Elias Halabu
Files at ZSQR (Coeptis Therapeutics Holdings, Inc.). First filing -, latest -.
In brief
David Elias Halabu files SEC Form 4 as CEO and director at ZSQR (Coeptis Therapeutics Holdings, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; David Elias Halabu has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 27, 2026 | ZSQR Coeptis Therapeutics Holdings, Inc. | MOption exercise Common Stock | +19,737 | $0.00 | $0 | 19,737 | 12 d ago |
| Apr 27, 2026 | ZSQR Coeptis Therapeutics Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative | +78,947 | $0.00 | $0 | 78,947 | 12 d ago |
| Jul 27, 2026 | ZSQR Coeptis Therapeutics Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -19,737 | $0.00 | $0 | 59,210 | 12 d ago |
| Apr 27, 2026 | ZSQR Coeptis Therapeutics Holdings, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +500,000 | $0.00 | $0 | 500,000 | Apr 30, 2026 |
Questions about David Elias Halabu
Answered from the filings on this page, as of the latest one.
Is David Elias Halabu buying or selling?
David Elias Halabu has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did David Elias Halabu's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David Elias Halabu has 0.
Where does David Elias Halabu file Form 4?
David Elias Halabu has filed Form 4 at ZSQR (Coeptis Therapeutics Holdings, Inc.) as Co-Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.